Administration of Nicotinamide Mononucleotide (NMN) Reduces Metabolic Impairment in Male Mouse Offspring from Obese Mothers
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Maternal obesity impacts offspring metabolism. We sought to boost mitochondrial energy metabolism using the nicotinamide adenine dinucleotide (NAD+) precursor nicotinamide mononucleotide (NMN) to treat metabolic impairment induced by maternal and long-term post weaning over-nutrition. Male offspring of lean or obese mothers, fed chow or high fat diet (HFD) for 30 weeks post-weaning, were given NMN injection, starting at 31 weeks of age, daily for 3 weeks before sacrifice. Glucose tolerance was tested at 10, 29 and 32 weeks of age to measure short and long term effects of post-weaning HFD, and NMN treatment. Plasma insulin and triglycerides, liver triglycerides and expression of mitochondrial metabolism-related genes were measured at 34 weeks. Impaired glucose tolerance due to maternal and post weaning HFD was significantly improved by only 8 days of NMN treatment. Furthermore, in offspring of obese mothers hepatic lipid accumulation was reduced due to NMN treatment by 50% and 23% in chow and HFD fed offspring respectively. Hepatic genes involved in fat synthesis, transport and uptake were reduced, while those involved in fatty acid oxidation were increased by NMN. Overall this finding suggests short term administration of NMN could be a therapeutic approach for treating metabolic disease due to maternal and post weaning over-nutrition, even in late adulthood.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, in relation to glucose tolerance, NMN was beneficial only for the most metabolically compromised mice group (feed HFD and from obese progenitress). In addition, NMN impaired glucose tolerance in mice from lean progenitress consuming chow and had no additional impact in offspring consuming HFD [115].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [115]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Male offspring of both lean and obese progenitress mice, fed either chow or high-fat diet (HFD) for 30 weeks post-weaning were intraperitoneally injected with NMN (500 mg/kg body weight) for 21 days. These mice had reduced adiposity, and hepatic and plasma triglyceride levels.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [115]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NMN also demonstrated no benefic effect on glucose metabolism in mice consuming a chow diet.”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [115]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070 · cited 2×
“Mitochondrial dysfunction in muscle and liver is a key mediating mechanism for obesity-related diseases such as insulin resistance and T2D [10,11].”
BackgroundGomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
Self-citationYoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340 · cited 3×
“daily for 21 days before sacrifice, 500 mg/kg body weight [14,18,23].”
BackgroundThe Global Epidemic of Obesity: An Overview
Caballero, B. (2007) · Epidemiologic Reviews · doi:10.1093/epirev/mxm012 · Cited by 1,250
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · cited 1×
“NR supplementation in food (200–400 mg/kg, ranging from 8–18 weeks) has been shown in multiple studies with HFD fed male mice to protect against body weight gain, to improve glucose tolerance, and to reduce hepatic steatosis, [16,30], lipid accumulation, liver fibrosis [31], and hepatic ER stress [32].”
BackgroundOrigins of lifetime health around the time of conception: causes and consequences
Fleming, T. P., Watkins, A. J., Velazquez, M. A., Mathers, J. C., Prentice, A. M., Stephenson, J., Barker, M., Saffery, R., Yajnik, C. S., Eckert, J. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30312-x · Cited by 1,147
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
Influence of Maternal Obesity on the Long-Term Health of Offspring
Godfrey, K. M., Reynolds, R. M., Prescott, S. L., Nyirenda, M., Jaddoe, V. W. V., Eriksson, J. G., & Broekman, B. F. P. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30107-3 · Cited by 1,059 · cited 1×
“with increased risk for obesity and metabolic disease in offspring [7].”
BackgroundMills, K. F., Yoshida, S., Stein, L. R., Grozio, A., Kubota, S., Sasaki, Y., Redpath, P., Migaud, M. E., Apte, R. S., Uchida, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.013 · Cited by 930 · cited 2×
“It is not clear whether these findings relate to the bolus administration of NMN, as long term administration of NMN (12 months) in drinking water was shown to improve glucose tolerance in chow-fed older mice [17].”
BackgroundJheng, H.-F., Tsai, P.-J., Guo, S.-M., Kuo, L.-H., Chang, C.-S., Su, I.-J., Chang, C.-R., & Tsai, Y.-S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05603-11 · Cited by 650 · cited 2×
“Mitochondrial dysfunction in muscle and liver is a key mediating mechanism for obesity-related diseases such as insulin resistance and T2D [10,11].”
BackgroundNAD + metabolism: Bioenergetics, signaling and manipulation for therapy
Yang, Y., & Sauve, A. A. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.06.014 · Cited by 497 · cited 1×
“Beyond ATP generation, in recent years’ interest has grown in the role of NAD+ as a central signalling molecule and enzyme substrate in many other fundamental biological processes including lifespan regulation, DNA repair, apoptosis, and telomere maintenance [13].”
BackgroundGariani, K., Menzies, K. J., Ryu, D., Wegner, C. J., Wang, X., Ropelle, E. R., Moullan, N., Zhang, H., Perino, A., Lemos, V., et al. (2016) · Hepatology · doi:10.1002/hep.28245 · Cited by 368 · cited 1×
“Various rodent studies that used single or multiple NMN doses (range 300–500 mg/kg) have shown beneficial effects in cardiac injury [33], heart failure [34], improved brain function and memory [35], enhanced mitochondrial oxidative metabolism [36] and hepatic mitochondrial respiration [15].”
Early Life Nutrition, Epigenetics and Programming of Later Life Disease
Vickers, M. (2014) · Nutrients · doi:10.3390/nu6062165 · Cited by 366 · cited 1×
“Also, it has been reported that early life developmental issues strongly associate with the prevalence of obesity and related metabolic disorders later in life [5,6].”
BackgroundNormalization of NAD + Redox Balance as a Therapy for Heart Failure
Lee, C. F., Chavez, J. D., Garcia-Menendez, L., Choi, Y., Roe, N. D., Chiao, Y. A., Edgar, J. S., Goo, Y. A., Goodlett, D. R., Bruce, J. E., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022495 · Cited by 336 · cited 1×
“Various rodent studies that used single or multiple NMN doses (range 300–500 mg/kg) have shown beneficial effects in cardiac injury [33], heart failure [34], improved brain function and memory [35], enhanced mitochondrial oxidative metabolism [36] and hepatic mitochondrial respiration [15].”
BackgroundYamamoto, T., Byun, J., Zhai, P., Ikeda, Y., Oka, S., & Sadoshima, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098972 · Cited by 305 · cited 1×
“Various rodent studies that used single or multiple NMN doses (range 300–500 mg/kg) have shown beneficial effects in cardiac injury [33], heart failure [34], improved brain function and memory [35], enhanced mitochondrial oxidative metabolism [36] and hepatic mitochondrial respiration [15].”
BackgroundNicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice
Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C. (2016) · Scientific Reports · doi:10.1038/srep26933 · Cited by 301 · cited 1×
“NR supplementation in food (200–400 mg/kg, ranging from 8–18 weeks) has been shown in multiple studies with HFD fed male mice to protect against body weight gain, to improve glucose tolerance, and to reduce hepatic steatosis, [16,30], lipid accumulation, liver fibrosis [31], and hepatic ER stress [32].”
BackgroundMaternal and Postnatal Overnutrition Differentially Impact Appetite Regulators and Fuel Metabolism
Chen, H., Simar, D., Lambert, K., Mercier, J., & Morris, M. J. (2008) · Endocrinology · doi:10.1210/en.2008-0582 · Cited by 265
Self-citationElahi, M. M., Cagampang, F. R., Mukhtar, D., Anthony, F. W., Ohri, S. K., & Hanson, M. A. (2009) · British Journal of Nutrition · doi:10.1017/s000711450820749x · Cited by 254
Maternal obesity and high-fat diet program offspring metabolic syndrome
Desai, M., Jellyman, J. K., Han, G., Beall, M., Lane, R. H., & Ross, M. G. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.03.025 · Cited by 244
Wang, X., Hu, X., Yang, Y., Takata, T., & Sakurai, T. (2016) · Brain Research · doi:10.1016/j.brainres.2016.04.060 · Cited by 217 · cited 1×
“Various rodent studies that used single or multiple NMN doses (range 300–500 mg/kg) have shown beneficial effects in cardiac injury [33], heart failure [34], improved brain function and memory [35], enhanced mitochondrial oxidative metabolism [36] and hepatic mitochondrial respiration [15].”
BackgroundStromsdorfer, K. L., Yamaguchi, S., Yoon, M. J., Moseley, A. C., Franczyk, M. P., Kelly, S. C., Qi, N., Imai, S.-I., & Yoshino, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.027 · Cited by 213 · cited 1×
“Alternatively, a recent study showed that insulin resistance in adipocyte specific Nampt knockout mice was improved by NMN treatment [42].”
BackgroundHepatic NAD+ deficiency as a therapeutic target for non‐alcoholic fatty liver disease in ageing
Zhou, C., Yang, X., Hua, X., Liu, J., Fan, M., Li, G., Song, J., Xu, T., Li, Z., Guan, Y., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13513 · Cited by 199 · cited 1×
“NR supplementation in food (200–400 mg/kg, ranging from 8–18 weeks) has been shown in multiple studies with HFD fed male mice to protect against body weight gain, to improve glucose tolerance, and to reduce hepatic steatosis, [16,30], lipid accumulation, liver fibrosis [31], and hepatic ER stress [32].”
BackgroundPediatric obesity: Causes, symptoms, prevention and treatment
XU, S., & XUE, Y. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2853 · Cited by 190 · cited 1×
“Childhood obesity can lead to serious complications and lifelong diseases like cardiac disorders, type 2 diabetes (T2D), psychological complications, pulmonary disorders, and exercise intolerance [3].”
BackgroundLong, N. M., George, L. A., Uthlaut, A. B., Smith, D. T., Nijland, M. J., Nathanielsz, P. W., & Ford, S. P. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-3083 · Cited by 170
Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2288-0 · Cited by 140 · cited 2×
“This explanation is supported by another study that showed that NMN supplementation improved glucose stimulated insulin secretion in isolated β-cells from fructose-fed mice that had pancreatic islet dysfunction [37].”
BackgroundResultAyonrinde, O. T., Oddy, W. H., Adams, L. A., Mori, T. A., Beilin, L. J., de Klerk, N. H., & Olynyk, J. K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.03.029 · Cited by 132 · cited 1×
“Maternal obesity is associated with non-alcoholic fatty liver disease (NAFLD) in adolescent offspring [8].”
BackgroundWu, Q., & Suzuki, M. (2006) · Obesity Reviews · doi:10.1111/j.1467-789x.2006.00232.x · Cited by 124 · cited 1×
“Parental overweight (body mass index (BMI) > 25) is considered as a key contributor to the risk of being overweight or obese in early life [4].”
BackgroundKruse, M., Seki, Y., Vuguin, P. M., Du, X. Q., Fiallo, A., Glenn, A. S., Singer, S., Breuhahn, K., Katz, E. B., & Charron, M. J. (2013) · Endocrinology · doi:10.1210/en.2012-1877 · Cited by 101 · cited 1×
“Others reported that there were no maternal HFD impacts on glucose levels when male mice offspring consumed chow for 23 weeks [43].”
BackgroundDepot- and sex-specific effects of maternal obesity in offspring’s adipose tissue
Lecoutre, S., Deracinois, B., Laborie, C., Eberlé, D., Guinez, C., Panchenko, P. E., Lésage, J., Vieau, D., Junien, C., Gabory, A., et al. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0037 · Cited by 100
Uddin, G. M., Youngson, N. A., Sinclair, D. A., & Morris, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00258 · Cited by 95 · cited 6×
“In our previous NMN studies adult female mice received HFD for 12 weeks [23] or 18 weeks in combination maternal HFD [18].”
BackgroundMethodResultInfluentialSelf-citationRaipuria, M., Bahari, H., & Morris, M. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120980 · Cited by 90 · cited 1×
“Therefore, our studies add to others which suggest that male offspring of obese mothers may be more prone to obesity than female offspring [45,46].”
ResultSelf-citationUddin, G. M., Youngson, N. A., Doyle, B. M., Sinclair, D. A., & Morris, M. J. (2017) · Scientific Reports · doi:10.1038/s41598-017-14866-z · Cited by 80 · cited 11×
“Also, we demonstrated that only 18 days of NMN injection improved glucose tolerance, reduced lipid accumulation and upregulated genes responsible for fatty acid metabolism in female offspring of obese mothers [18].”
BackgroundMethodResultInfluentialSelf-citationBoyle, K. E., Patinkin, Z. W., Shapiro, A. L. B., Bader, C., Vanderlinden, L., Kechris, K., Janssen, R. C., Ford, R. J., Smith, B. K., Steinberg, G. R., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.012 · Cited by 74 · cited 1×
“Furthermore, mesenchymal stem cells of newborns from obese mothers showed greater lipid accumulation, lower fatty acid oxidation, dysregulation of AMPK (adenosine monophosphate-activated protein kinase) activity and downregulation of genes responsible for fatty acid oxidation [9].”
BackgroundXiao, D., Huang, X., Lawrence, J., Yang, S., & Zhang, L. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.113332 · Cited by 72 · cited 1×
“Therefore, our studies add to others which suggest that male offspring of obese mothers may be more prone to obesity than female offspring [45,46].”
ResultWang, X., Zhang, Z.-F., Zheng, G., Wang, A., Sun, C., Qin, S., Zhuang, J., Lu, J. L., Ma, D., & Zheng, Y. (2017) · Molecules · doi:10.3390/molecules22081315 · Cited by 64 · cited 1×
“NR supplementation in food (200–400 mg/kg, ranging from 8–18 weeks) has been shown in multiple studies with HFD fed male mice to protect against body weight gain, to improve glucose tolerance, and to reduce hepatic steatosis, [16,30], lipid accumulation, liver fibrosis [31], and hepatic ER stress [32].”
BackgroundMitochondrial sirtuins and metabolic homeostasis
Pirinen, E., Lo Sasso, G., & Auwerx, J. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2012.05.001 · Cited by 56 · cited 1×
“The reduction of NAD+ to NADH, during mitochondrial β-oxidation, glycolysis and the TCA cycle, and the reverse process, oxidation in oxidative phosphorylation, makes NAD+ a key component of mitochondrial energy generation [12].”
BackgroundRodríguez, L., Otero, P., Panadero, M. I., Rodrigo, S., Álvarez‐Millán, J. J., & Bocos, C. (2015) · Journal of Nutrition and Metabolism · doi:10.1155/2015/158091 · Cited by 53
Fu, L., Bruckbauer, A., Li, F., Cao, Q., Cui, X., Wu, R., Shi, H., Zemel, M. B., & Xue, B. (2015) · Metabolism · doi:10.1016/j.metabol.2015.07.006 · Cited by 49 · cited 1×
“leucine, metformin, and exendin-4, superoxide dismutase mimetic and peroxynitrite supplementation for 5–8 weeks have been shown to reduce circulating and hepatic triglyceride accumulation in HFD fed obese rats and mice [38,39].”
BackgroundCostford, S. R., Brouwers, B., Hopf, M. E., Sparks, L. M., Dispagna, M., Gomes, A. P., Cornnell, H. H., Petucci, C., Phelan, P., Xie, H., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2017.10.012 · Cited by 49
Self-citationDall, M., Penke, M., Sulek, K., Matz‐Soja, M., Holst, B., Garten, A., Kieß, W., & Treebak, J. T. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.025 · Cited by 46
Bahari, H., Caruso, V., & Morris, M. J. (2013) · Endocrinology · doi:10.1210/en.2013-1059 · Cited by 42 · cited 1×
“Furthermore, these impacts are known to be exacerbated by post-weaning HFD consumption [18,27,28], and in this study mice exposed to both insults, maternal obesity and chronic post-weaning HFD, were twice as heavy as CCV controls.”
BackgroundSelf-citationEarly life influences on obesity risk: maternal overnutrition and programming of obesity
Morris, M. J. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.45 · Cited by 39 · cited 1×
“Also, it has been reported that early life developmental issues strongly associate with the prevalence of obesity and related metabolic disorders later in life [5,6].”
BackgroundSelf-citationOostvogels, A. J. J. M., Hof, M. H. P., Gademan, M. G. J., Roseboom, T. J., Stronks, K., & Vrijkotte, T. G. M. (2017) · Early Human Development · doi:10.1016/j.earlhumdev.2017.06.002 · Cited by 28 · cited 2×
“Investigating both male and female offspring is important due to the differences that have been reported in both human [19] and rodent studies [20–22] on the scale of changes in growth and adiposity of offspring.”
BackgroundResultChan, Y. L., Saad, S., Simar, D., Oliver, B. G. G., McGrath, K. C. Y., van Reyk, D. M., Bertrand, P. P., Gorrie, C. A., Pollock, C. A., & Chen, H. (2015) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2015.05.009 · Cited by 12 · cited 1×
“leucine, metformin, and exendin-4, superoxide dismutase mimetic and peroxynitrite supplementation for 5–8 weeks have been shown to reduce circulating and hepatic triglyceride accumulation in HFD fed obese rats and mice [38,39].”
BackgroundDietz, W. H. (2016) · Obesity · doi:10.1002/oby.21518 · Cited by 9 · cited 1×
“As with obesity in adults, the prevalence of childhood obesity is rising across the world [2].”
BackgroundXiao, D., Kou, H., Zhang, L., Guo, Y., & Wang, H. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.01.002 · Cited by 8 · cited 1×
“Furthermore, these impacts are known to be exacerbated by post-weaning HFD consumption [18,27,28], and in this study mice exposed to both insults, maternal obesity and chronic post-weaning HFD, were twice as heavy as CCV controls.”
Background
Cited by
Alegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health
Campagna, R., & Vignini, A. (2023) · Antioxidants · doi:10.3390/antiox12020376 · Cited by 80
Huang, Z., Li, N., Yu, S., Zhang, W., Zhang, T., & Zhou, J. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00100 · Cited by 76
Fukamizu, Y., Uchida, Y., Shigekawa, A., Sato, T., Kosaka, H., & Sakurai, T. (2022) · Scientific Reports · doi:10.1038/s41598-022-18272-y · Cited by 69
Niu, K., Bao, T., Gao, L., Ru, M., Li, Y., Jiang, L., Ye, C., Wang, S., & Wu, X. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.756243 · Cited by 60
“The reduction of metabolic impairment in obese mice has been reported in NMN supplementation (13, 14).”
Background
Metadata
- Authors
- Uddin, G. M., Youngson, N. A., Chowdhury, S. S., Hagan, C., Sinclair, D. A., & Morris, M. J.
- Affiliations
- UNSW Sydney (AU)
- Harvard University (US)
- Corresponding author
- Morris, Margaret J.
- ORCID
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-03-25
- Volume
- 9
- Issue
- 4
- Pages
- 791
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7226525
- OpenAlex
- W3013472836
- Cited by
- 32
- References
- 46
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 6 · 2023: 9 · 2022: 5 · 2021: 4 · 2020: 2
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Health and Medical Research Council (APP1044295)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- nicotinamide mononucleotide, maternal obesity, glucose tolerance, hepatic lipid accumulation, fatty acid oxidation, mitochondrial metabolism, insulin, triglycerides, metabolic dysfunction, male offspring, metabolic disorders
- MeSH terms
- Animals, Organelle Biogenesis, Body Weight, Diet, Female, Gene Expression Regulation, Glucose Tolerance Test, Insulin, Liver, Male, Mice, Inbred C57BL, Mice, Obese, Nicotinamide Mononucleotide, Obesity, Phenotype, Triglycerides, Weaning, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.